Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H16F6N2O.ClH |
Molecular Weight | 414.773 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[H][C@@]1(CCCCN1)[C@@H](O)C2=C3C=CC=C(C3=NC(=C2)C(F)(F)F)C(F)(F)F
InChI
InChIKey=WESWYMRNZNDGBX-YLCXCWDSSA-N
InChI=1S/C17H16F6N2O.ClH/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11;/h3-5,8,12,15,24,26H,1-2,6-7H2;1H/t12-,15+;/m1./s1
Molecular Formula | C17H16F6N2O |
Molecular Weight | 378.3122 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:24:53 UTC 2023
by
admin
on
Fri Dec 15 15:24:53 UTC 2023
|
Record UNII |
5Y9L3636O3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
18687
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
||
|
NCI_THESAURUS |
C271
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
||
|
FDA ORPHAN DRUG |
26287
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
W-48
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
DBSALT000311
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
51773-92-3
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
SUB14492MIG
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
65329
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
157387
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
DTXSID1047819
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
C47600
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
CHEMBL416956
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
100000076533
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
5Y9L3636O3
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
5Y9L3636O3
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
1379059
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
82130
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | RxNorm | ||
|
257-412-0
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | |||
|
m7142
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | Merck Index | ||
|
MEFLOQUINE HYDROCHLORIDE
Created by
admin on Fri Dec 15 15:24:53 UTC 2023 , Edited by admin on Fri Dec 15 15:24:53 UTC 2023
|
PRIMARY | Description: A white to slightly yellow, crystalline powder. Solubility: Very slightly soluble in water; freely soluble in methanol R; soluble in ethanol (~750 g/L) TS; sparingly soluble in dichloromethane R. Category: Antimalarial. Storage: Mefloquine hydrochloride should be kept in a tightly closed container, protected from light. Additional information: Mefloquine hydrochloride may exhibit polymorphism. It melts at about 260 ?C, with decomposition. Requirement: Mefloquine hydrochloride contains not less than 99.0% and not more than 101.0% of C17H16F6N2O,HCl, calculated with reference to the anhydrous substance. |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
MEFLOQUINE HYDROCHLORIDE Impurity A.
In the chromatogram obtained with solution (1) the following impurities, if present, are eluted at the following relative retention with reference to mefloquine (retention time about 3.9 minutes): impurity A about 0.9. In the chromatogram obtained with solution (1):the area of any peak corresponding to impurity A is not greater than the area of the principal peak in the chromatogram obtained with solution (2) (0.2%).
|
||
|
IMPURITY -> PARENT |
MEFLOQUINE HYDROCHLORIDE Impurity B.
In the chromatogram obtained with solution (1) the following impurity, if present, is eluted at the following relative retention with reference to mefloquine (retention time about 3.9 minutes): impurity B about 7.4.
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |